Safety review of tumor necrosis factor blockers

NEWS IN BRIEF — Posted June 23, 2008

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration on June 4 announced that it is conducting a safety review of several drugs known as tumor necrosis factor blockers.

The drugs Enbrel, Humira, Remicade and Cimzia, all of which are used to treat juvenile idiopathic arthritis and Crohn's disease, are being reviewed for a possible association with the development of lymphoma and other cancers in children and young adults.

During the review, which may take up to six months to complete, the FDA is advising prescribers to weigh the possible association with lymphoma and other cancers against the benefits of treatment with the medications.

The agency also is urging physicians and patients to report side effects from the drugs under review to the MedWatch Adverse Event Reporting program either by calling 800-332-1088 or online (link).

Note: This item originally appeared at

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn